These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9530359)

  • 1. [Phase I study of orally administered UFT plus l-leucovorin].
    Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):531-9. PubMed ID: 9530359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
    Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
    Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal.
    González Barón M; Feliu J; Ordoñez A; Colmenarejo A; Espinosa E; Zamora P; de la Gandara I; Jalon JI
    Anticancer Res; 1993; 13(3):759-62. PubMed ID: 8317909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
    Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase I study of 5-fluorouracil and l-leucovorin].
    Sasaki T; Ota K; Wakui A; Akazawa S; Ogawa M; Ariyoshi Y; Yura J; Inagaki J; Hoshino A; Abe T
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):485-91. PubMed ID: 8452386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
    Byström P; Frödin JE; Berglund A; Wilking N; Glimelius B
    Radiother Oncol; 2004 Feb; 70(2):171-5. PubMed ID: 15028404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.
    Passardi A; Maltoni R; Milandri C; Cecconetto L; Massa I; Zoli W; Tesei A; Fabbri F; Nanni O; Amadori D
    Oncology; 2007; 72(1-2):118-24. PubMed ID: 18004083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
    Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UFT in combination with oxaliplatin: clinical phase I study in patients with advanced or metastatic solid tumors.
    Sastre J; Aranda E; Abad A; Gallego J; Manzano JL; Gómez A; Carrato A; López E; Díaz-Rubio E;
    Anticancer Drugs; 2006 Apr; 17(4):417-21. PubMed ID: 16549999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
    Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B
    J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer].
    Sakuyama T; Yokoyama M; Ogawa M; Takao Y; Sato K; Kawahara H; Anazawa S; Yamazaki Y; Hirai K
    Gan To Kagaku Ryoho; 2004 May; 31(5):771-5. PubMed ID: 15170991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
    Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
    Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
    Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.
    Pazdur R; Lassere Y; Diaz-Canton E; Bready B; Ho DH
    Invest New Drugs; 1997; 15(2):123-8. PubMed ID: 9220291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
    Sakata Y; Chiba Y; Sato T; Kimura M; Fukushi G; Matsukawa M; Wada K; Aoyama H; Sawada Y; Fukushi M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):195-201. PubMed ID: 1736831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
    Toyokawa A; Tsujimura T; Hamabe Y; Sato S; Mukubou H; Wakahara T; Kaji M; Tsukamoto T; Wakita K; Onishi N; Ishida T; Watanabe A; Fujiwara H; Mukai H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.